Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition:   ObesityInterventions:   Drug: Canagliflozin;   Drug: Phentermine;   Drug: Matching Placebo to Canagliflozin;   Drug: Matching Placebo to PhentermineSponsor:   Janssen Research & Development, LLCRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition:   ObesityInterventions:   Drug: Canagliflozin;   Drug: Phentermine;   Drug: Matching Placebo to Canagliflozin;   Drug: Matching Placebo to PhentermineSponsor:   Janssen Research & Development, LLCRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition:   ObesityInterventions:   Drug: Canagliflozin;   Drug: Phentermine;   Drug: Matching Placebo to Canagliflozin;   Drug: Matching Placebo to PhentermineSponsor:   Janssen Research & Development, LLCRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition:   ObesityInterventions:   Drug: Canagliflozin;   Drug: Phentermine;   Drug: Matching Placebo to Canagliflozin;   Drug: Matching Placebo to PhentermineSponsor:   Janssen Research & Development, LLCActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2014 Category: Research Source Type: clinical trials

Topiramate-Phentermine Combinations for Cocaine Dependence
Condition:   Cocaine Use DisorderInterventions:   Drug: Cocaine;   Drug: Placebo;   Drug: Phentermine;   Drug: TopiramateSponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials